Transforming growth factor-β1 in experimental autoimmune neuritis: Cellular localization and time course

American Journal of Pathology

Volumn 148, Issue 1, 1996, Pages 211-223

  Kiefer, Reinhard ^a   Funa, Keiko ^b   Schweitzer, Tilmann ^a   Jung, Stefan ^a   Bourde, Odile ^a   Toyka, Klaus V ^a   Hartung, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; ETIOLOGY; FEMALE; IN SITU HYBRIDIZATION; MACROPHAGE; MONONUCLEAR CELL; MOTOR NERVE; NEURITIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SENSORY NERVE; SPINAL GANGLION; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; BLOTTING, NORTHERN; FEMALE; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEURITIS; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, INBRED LEW; RNA, MESSENGER; SCIATIC NERVE; SPINAL NERVE ROOTS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030030568     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H: A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 1984, 133:1946-1950
2. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens, induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992, 22:1813-1817
3. Hartung H-P, Pollard JD, Harvey GK, Toyka KV Immunopathogenesis and treatment of the Guillain-Barré syndrome, parts I and II Muscle & Nerve 1995, 18 137-164
4. Zettl UK, Gold R, Hartung H-P, Toyka KV. Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci Lett 1994, 176.75-79
5. Hartung H-P, Schäfer B, van der Meide PH, Fierz W, Heininger K, Toyka KV The role of interferon-γ in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neural 1990, 27: 247-257
6. Hartung H-P, Schäfer B, Diamantstein T, Fierz W, Heininger K, Toyka KV: Suppression of P2-T cell line mediated experimental autoimmune neuritis by interleukin 2-receptor targeted monoclonal antibody ART 18 Brain Res 1989, 489:120-128
7. Massagué J, Attisano L, Wrana JL: The TGF-β family, and its composite receptors Trends Cell Biol 1994, 4:172-178
8. Sporn MB, Roberts AB: Transforming growth factor-β. recent progress and new challenges. J Cell Biol 1992, 119 1017-1021
9. Johns LD, Flanders KC, Ranges GE, Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β 1 J Immunol 1991, 147 1792-1796
10. Racke MK, Dhib Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE: Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β 1 J Immunol 1991, 146. 3012-3017
11. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice Proc Natl Acad Sci USA 1991, 88.2918-2921
12. Gregorian SK, Lee WP, Beck LS, Rostami A, Amento EP. Regulation of experimental autoimmune neuritis by transforming growth factor-β1 Cell Immunol 1994, 156 102-112
13. Jung S, Schluesener HJ, Schmidt B, Fontana A, Toyka KV, Hartung H-P: Therapeutic effect of transforming growth factor-β2 on actively induced EAN but not adoptive transfer EAN. Immunology 1994, 83 545-551
14. Johns LD, Sriram S: Experimental allergic encephalomyelitis: neutralizing antibody to TGF-β1 enhances the clinical severity of the disease. J Neuroimmunol 1993, 47:1-7
15. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE: Evidence of endogenous regulatory function of transforming growth factor-β 1 in experimental allergic encephalomyelitis. Int Immunol 1992, 4:615-620
16. Hartung H-P, Heininger K, Schäfer B, Fierz W, Toyka KV: Immune mechanisms in inflammatory polyneuropathy Ann NY Acad Sci 1988, 545:122-161
17. Jung S, Krämer S, Schluesener HJ, Hunig T, Toyka K, Hartung H-P: Prevention and therapy of experimental allergic neuritis by an antibody against T cell receptor-α/β. J Immunol 1992, 148:3768-3775
18. Kiefer R, Lindholm D, Kreutzberg GW. Interleukin-6 and transforming growth factor-β1 mRNAs are induced in rat facial nucleus following motoneuron axotomy Eur J Neurosci 1993, 5:775-781
19. Kiefer R, Gold R, Gehrmann J, Lindholm D, Wekerle H, Kreutzberg GW: Transforming growth factor β expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis J Neurosci Res 1993, 36:391-398
20. Kiefer R, Kreutzberg GW. Gamma interferon-like immunoreactivity in the rat nervous system Neuroscience 1990, 37 725-734
21. Olofsson A, Miyazono K, Kanzaki T, Colosetti P Engström U, Heldin C-H: Transforming growth factor-β1, -β2, and -β3 secreted by human glioblastoma cell line. J Biol Chem 1992, 267 19482-19488
22. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM: Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β J Exp Med 1990, 171 231-247
23. Weinberg AD, Whitham R, Swain SL, Morrison WJ, Wyrick G, Hoy C, Vandenbark AA, Offner H: Transforming growth factor-β enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental allergic encephalomyelitis J Immunol 1992, 148:2109-2117
24. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359 693-699
25. Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993, 90 770-774
26. Kennedy MK, Torrance DS, Picha KS, Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery J Immunol 1992, 149:2496-2505
27. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987, 84.6020-6024 (Abstr)
28. + suppressor cells inhibit the function of effector cells of experimental allergic encephalomyelitis through a mechanism involving transforming growth factor-β. J Immunol 1991, 146: 1163-1168
29. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. J Immunol 1992, 89:421-425
30. Scherer SS, Kamholz J, Jakowlew SB: Axons modulate the expression of transforming growth factor-betas in Schwann cells. Glia 1993, 8 265-276
31. Rufer M, Flanders K, Unsicker K: Presence and regulation of transforming growth factor β mRNA and protein in the normal and lesioned rat sciatic nerve J Neurosci Res 1994, 39:412-423
32. Mews M, Meyer M: Modulation of Schwann cell phenotype by TGF-β 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor Glia 1993, 8:208-217
33. Heininger K, Stoll G, Linington C, Toyka KV, Wekerle H. Conduction failure and slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Ann Neurol 1986, 19:44-49
34. Kiefer R, Streit WJ, Toyka KV, Kreutzberg GW, Hartung H-P Transforming growth factor-β1 a lesion-associated cytokine of the nervous system. Int J Dev Neurosci 1995, 13:331-339
35. Eccleston PA, Jessen KR, Mirsky R Transforming growth factor-β and γ-interferon have dual effects on growth of peripheral glia. J Neurosci Res 1989, 24: 524-530
36. Ridley AJ, Davis JB, Stroobant P, Land H. Transforming growth factors-β1 and β2 are mitogens for rat Schwann cells. J Cell Biol 1989, 109 3419-3424
37. Chalazonitis A, Kalberg J, Twardzik DR, Morrison RS, Kessler JA Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor Dev Biol 1992, 152 121-132
38. Martinou J-C, Le Van Thai A, Valette A, Weber MJ. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture. Dev Brain Res 1990, 52.175-181
39. Morgan L, Jessen K, Mirsky R: Negative regulation of the P0 gene in Schwann cells, suppression of P0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGFβ1, TGFβ2 and TGFβ3. Development 1994, 120:1399-1409
40. Saad B, Constam DB, Ortmann R, Moos M, Fontana A, Schachner M: Astrocyte-derived TGF-β2, and NGF differentially regulate neural recognition molecule expression by cultured astrocytes. J Cell Biol 1991, 115:473-484
41. Lindholm D, Hengerer B, Zafra F, Thoenen H: Transforming growth factor-β 1 stimulates expression of nerve growth factor in the rat CNS Neuroreport 1990, 1:9-12
42. Lindholm D, Heumann R, Meyer M, Thoenen H: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987, 330:658-659
43. Stoll G, Jung S, Jander S, van der Meide P, Hartung H-P: Tumor necrosis factor-α in immune mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993, 45: 175-182
44. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988, 334:260-262